Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis

Timothy P. Carr, John S. Parks, Lawrence L. Rudel

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

Previous studies and this study of African green monkeys show a strong positive correlation between plasma low density lipoprotein (LDL) size and the extent of coronary artery atherosclerosis (CAA). Increased LDL size was principally due to the accumulation of cholesteryl oleate molecules within the particle core, suggesting that many of these cholesteryl esters were of tissue origin, i.e., from the acyl-coenzyme A: cholesterol acyltransferase (ACAT) reaction instead of the lecithin:cholesterol acyltransferase (LCAT) reaction. The current study was conducted to test the hypothesis that ACAT in the liver is the source of the increased numbers of cholesteryl oleate molecules in plasma LDL particles that appear to increase the atherogenic potential of LDL. Monkeys were fed diets rich in fat (lard, safflower oil, or fish oil) and cholesterol for 3-6 years before liver perfusion, ACAT assay, and evaluation of CAA. Hepatic ACAT activity was positively correlated with hepatic cholesteryl ester secretion (r=0.61, p<0.001), plasma LDL cholesteryl ester content (r=0.60, p<0.0001), and the extent of CAA (r=0.62, p<0.0001). The number of cholesteryl oleate molecules within LDL increased proportionally with LDL size in each of the diet groups. Hepatic cholesteryl oleate concentration was correlated with the accumulation of cholesteryl oleate in liver perfusate (r=0.72, p<0.01) and with plasma LDL cholesterol oleate content (r=0.73, p<0.0001). Our interpretation is that these data, obtained in a relevant primate model of CAA, suggest that hepatic ACAT increases the atherogenicity of LDL by augmenting both the secretion by the liver and accumulation in plasma LDL of cholesteryl oleate.

Original languageEnglish (US)
Pages (from-to)1274-1283
Number of pages10
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume12
Issue number11
DOIs
StatePublished - Jan 1 1992

Fingerprint

Sterol O-Acyltransferase
Cercopithecus aethiops
Cholesterol Esters
LDL Lipoproteins
Coronary Artery Disease
Coronary Vessels
Liver
Safflower Oil
Diet
Phosphatidylcholine-Sterol O-Acyltransferase
Acyl Coenzyme A
Fish Oils
cholesteryl oleate
LDL Cholesterol
Primates
Haplorhini
Perfusion
Fats
Cholesterol

Keywords

  • Acyl-coenzyme A: cholesterol acyltransferase
  • Atherosclerosis
  • Cholesteryl ester
  • Hepatic secretion
  • Liver
  • Low density lipoproteins
  • Primates

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{61e47db205524978816c9713da3d8d35,
title = "Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis",
abstract = "Previous studies and this study of African green monkeys show a strong positive correlation between plasma low density lipoprotein (LDL) size and the extent of coronary artery atherosclerosis (CAA). Increased LDL size was principally due to the accumulation of cholesteryl oleate molecules within the particle core, suggesting that many of these cholesteryl esters were of tissue origin, i.e., from the acyl-coenzyme A: cholesterol acyltransferase (ACAT) reaction instead of the lecithin:cholesterol acyltransferase (LCAT) reaction. The current study was conducted to test the hypothesis that ACAT in the liver is the source of the increased numbers of cholesteryl oleate molecules in plasma LDL particles that appear to increase the atherogenic potential of LDL. Monkeys were fed diets rich in fat (lard, safflower oil, or fish oil) and cholesterol for 3-6 years before liver perfusion, ACAT assay, and evaluation of CAA. Hepatic ACAT activity was positively correlated with hepatic cholesteryl ester secretion (r=0.61, p<0.001), plasma LDL cholesteryl ester content (r=0.60, p<0.0001), and the extent of CAA (r=0.62, p<0.0001). The number of cholesteryl oleate molecules within LDL increased proportionally with LDL size in each of the diet groups. Hepatic cholesteryl oleate concentration was correlated with the accumulation of cholesteryl oleate in liver perfusate (r=0.72, p<0.01) and with plasma LDL cholesterol oleate content (r=0.73, p<0.0001). Our interpretation is that these data, obtained in a relevant primate model of CAA, suggest that hepatic ACAT increases the atherogenicity of LDL by augmenting both the secretion by the liver and accumulation in plasma LDL of cholesteryl oleate.",
keywords = "Acyl-coenzyme A: cholesterol acyltransferase, Atherosclerosis, Cholesteryl ester, Hepatic secretion, Liver, Low density lipoproteins, Primates",
author = "Carr, {Timothy P.} and Parks, {John S.} and Rudel, {Lawrence L.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1161/01.ATV.12.11.1274",
language = "English (US)",
volume = "12",
pages = "1274--1283",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis

AU - Carr, Timothy P.

AU - Parks, John S.

AU - Rudel, Lawrence L.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Previous studies and this study of African green monkeys show a strong positive correlation between plasma low density lipoprotein (LDL) size and the extent of coronary artery atherosclerosis (CAA). Increased LDL size was principally due to the accumulation of cholesteryl oleate molecules within the particle core, suggesting that many of these cholesteryl esters were of tissue origin, i.e., from the acyl-coenzyme A: cholesterol acyltransferase (ACAT) reaction instead of the lecithin:cholesterol acyltransferase (LCAT) reaction. The current study was conducted to test the hypothesis that ACAT in the liver is the source of the increased numbers of cholesteryl oleate molecules in plasma LDL particles that appear to increase the atherogenic potential of LDL. Monkeys were fed diets rich in fat (lard, safflower oil, or fish oil) and cholesterol for 3-6 years before liver perfusion, ACAT assay, and evaluation of CAA. Hepatic ACAT activity was positively correlated with hepatic cholesteryl ester secretion (r=0.61, p<0.001), plasma LDL cholesteryl ester content (r=0.60, p<0.0001), and the extent of CAA (r=0.62, p<0.0001). The number of cholesteryl oleate molecules within LDL increased proportionally with LDL size in each of the diet groups. Hepatic cholesteryl oleate concentration was correlated with the accumulation of cholesteryl oleate in liver perfusate (r=0.72, p<0.01) and with plasma LDL cholesterol oleate content (r=0.73, p<0.0001). Our interpretation is that these data, obtained in a relevant primate model of CAA, suggest that hepatic ACAT increases the atherogenicity of LDL by augmenting both the secretion by the liver and accumulation in plasma LDL of cholesteryl oleate.

AB - Previous studies and this study of African green monkeys show a strong positive correlation between plasma low density lipoprotein (LDL) size and the extent of coronary artery atherosclerosis (CAA). Increased LDL size was principally due to the accumulation of cholesteryl oleate molecules within the particle core, suggesting that many of these cholesteryl esters were of tissue origin, i.e., from the acyl-coenzyme A: cholesterol acyltransferase (ACAT) reaction instead of the lecithin:cholesterol acyltransferase (LCAT) reaction. The current study was conducted to test the hypothesis that ACAT in the liver is the source of the increased numbers of cholesteryl oleate molecules in plasma LDL particles that appear to increase the atherogenic potential of LDL. Monkeys were fed diets rich in fat (lard, safflower oil, or fish oil) and cholesterol for 3-6 years before liver perfusion, ACAT assay, and evaluation of CAA. Hepatic ACAT activity was positively correlated with hepatic cholesteryl ester secretion (r=0.61, p<0.001), plasma LDL cholesteryl ester content (r=0.60, p<0.0001), and the extent of CAA (r=0.62, p<0.0001). The number of cholesteryl oleate molecules within LDL increased proportionally with LDL size in each of the diet groups. Hepatic cholesteryl oleate concentration was correlated with the accumulation of cholesteryl oleate in liver perfusate (r=0.72, p<0.01) and with plasma LDL cholesterol oleate content (r=0.73, p<0.0001). Our interpretation is that these data, obtained in a relevant primate model of CAA, suggest that hepatic ACAT increases the atherogenicity of LDL by augmenting both the secretion by the liver and accumulation in plasma LDL of cholesteryl oleate.

KW - Acyl-coenzyme A: cholesterol acyltransferase

KW - Atherosclerosis

KW - Cholesteryl ester

KW - Hepatic secretion

KW - Liver

KW - Low density lipoproteins

KW - Primates

UR - http://www.scopus.com/inward/record.url?scp=0026442631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026442631&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.12.11.1274

DO - 10.1161/01.ATV.12.11.1274

M3 - Article

C2 - 1420087

AN - SCOPUS:0026442631

VL - 12

SP - 1274

EP - 1283

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 11

ER -